NOV
58
3
BIIB
26
2
FRT
39
-2
OXY
40
3
FOXA
55
9
EXPE
88
2
AXP
66
2
LH
42
2
EFX
32
2
PCG
93
2
AES
39
-4
VLO
40
-2
RRC
63
3
M
20
-4
SIG
43
3
IFF
53
2
VFC
47
-5
DLTR
34
-4
HIG
67
4
ILMN
32
-3
NOV
58
3
BIIB
26
2
FRT
39
-2
OXY
40
3
FOXA
55
9
EXPE
88
2
AXP
66
2
LH
42
2
EFX
32
2
PCG
93
2
AES
39
-4
VLO
40
-2
RRC
63
3
M
20
-4
SIG
43
3
IFF
53
2
VFC
47
-5
DLTR
34
-4
HIG
67
4
ILMN
32
-3
Financhill
Back

Addex Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
15

ADXN
Addex Therapeutics

Last Price:
7.80
Seasonality Move:
36.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Addex Therapeutics Price Quote

$7.80
+0.42 (+5.69%)
(Updated: November 21, 2024 at 1:30 PM ET)

Addex Therapeutics Key Stats

Sell
15
Addex Therapeutics (ADXN) is a Sell
Day range:
$7.33 - $7.82
52-week range:
$5.00 - $27.90
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.03
P/B ratio:
0.56%
Volume:
10.9K
Avg. volume:
45.2K
1-year change:
17.14%
Market cap:
$7.9M
Revenue:
$1.8M
EPS:
$-1.64

How Much Does Addex Therapeutics Make?

Is Addex Therapeutics Growing As A Company?

  • What Is Addex Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.82%
  • What Is Addex Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Addex Therapeutics Stock Price Performance

What Is Addex Therapeutics 52-Week High & Low?

Addex Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Addex Therapeutics?

Is Addex Therapeutics Cash Flow Positive?

  • What Is ADXN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.7M
  • What Is Addex Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$151K
  • What Is Addex Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $5.2M

Addex Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    ADXN return on invested capital is 90.28%
  • What Is Addex Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 54.9%
  • What Is ADXN Return On Equity?
    ROE is a measure of profitability and is 90.28%

Addex Therapeutics Earnings Date & Stock Price

Addex Therapeutics Competitors

Addex Therapeutics Dividend Yield

Addex Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -81.84% -47.81%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 30.00
Upside from Last Price: 306.5%

Major Shareholders

  • How many ADXN shares are owned by institutional investors?
    4.6M ADXN shares are owned by institutional investors
  • How many ADXN shares are owned by insiders?
    0 ADXN shares are owned by insiders